Nuvo Pharmaceuticals (OTCMKTS:NRIFF) released its quarterly earnings data on Wednesday. The company reported ($0.54) EPS for the quarter, Morningstar.com reports. Nuvo Pharmaceuticals had a negative return on equity of 21.93% and a negative net margin of 44.15%. The firm had revenue of $12.40 million during the quarter.
NRIFF stock traded up $0.08 during midday trading on Thursday, hitting $0.56. 1,000 shares of the company traded hands, compared to its average volume of 411. Nuvo Pharmaceuticals has a twelve month low of $0.45 and a twelve month high of $2.48. The company has a quick ratio of 1.91, a current ratio of 2.60 and a debt-to-equity ratio of 9.22. The firm’s 50 day simple moving average is $0.55.
About Nuvo Pharmaceuticals
See Also: How a Put Option Works
Receive News & Ratings for Nuvo Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvo Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.